Back

Clinical impact of early TTR stabilisation

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: The importance of transthyretin (TTR): optimising outcomes in ATTRv-CM and ATTRwt-CM Cardiac Amyloidosis Open Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Ahmad Masri

Oregon Health & Science University Medical Group, Portland (United States of America)

4 More presentations in this session

Presentation thumbnail
Introduction
Professor M. Fontana (London, GB)
Presentation thumbnail
TTR's vital role throughout the body
Professor M. Gertz (Rochester, US)
Presentation thumbnail
TTR stabilisation for the management of variant and Wild-Type ATTR-CM
Doctor N. Sarswat (Chicago, US)
Presentation thumbnail
Q&A

Access the full session

Session thumbnail
The importance of transthyretin (TTR): optimising outcomes in ATTRv-CM and ATTRwt-CM

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources